Skip to main content
. 2006 Aug 24;7(3):28–34. doi: 10.1120/jacmp.v7i3.2293

Figure 3. Dose modification factors at the prescription line 1 cm from the balloon's surface with various breast tissue thicknesses between the prescription line and the breast–lung interface.

Figure 3